Reduced hippocampal volume in adolescents with psychotic experiences: A longitudinal population-based study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 20 06 2019
accepted: 04 05 2020
entrez: 4 6 2020
pubmed: 4 6 2020
medline: 22 8 2020
Statut: epublish

Résumé

Smaller hippocampal volumes are among the most consistently reported neuroimaging findings in schizophrenia. However, little is known about hippocampal volumes in people who report psychotic experiences. This study investigated differences in hippocampal volume between young people without formal diagnoses who report psychotic experiences (PEs) and those who do not report such experiences. This study also investigated if any differences persisted over two years. A nested case-control study of 25 adolescents (mean age 13.5 years) with reported PEs and 25 matched controls (mean age 13.36 years) without PEs were drawn from a sample of 100 local schoolchildren. High-resolution T1-weighted anatomical imaging and subsequent automated cortical segmentation (Freesurfer 6.0) was undertaken to determine total hippocampal volumes. Comprehensive semi-structured clinical interviews were also performed including information on PEs, mental diagnoses and early life stress (bullying). Participants were invited for a second scan at two years. 19 adolescents with PEs and 19 controls completed both scans. Hippocampal volumes were bilaterally lower in the PE group compared to the controls with moderate effects sizes both at baseline [left hippocampus p = 0.024 d = 0.736, right hippocampus p = 0.018, d = 0.738] and at 2 year follow up [left hippocampus p = 0.027 d = 0.702, right = 0.048 d = 0.659] throughout. These differences survived adjustment for co-morbid mental disorders and early life stress. Psychotic experiences are associated with total hippocampal volume loss in young people and this volume loss appears to be independent of possible confounders such as co-morbid disorders and early life stress.

Identifiants

pubmed: 32492020
doi: 10.1371/journal.pone.0233670
pii: PONE-D-19-17483
pmc: PMC7269246
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0233670

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Acta Psychiatr Scand. 2013 Jan;127(1):34-47
pubmed: 22676336
Biol Psychiatry. 2010 Feb 15;67(4):357-64
pubmed: 20015483
Biol Psychiatry. 2016 May 15;79(10):840-849
pubmed: 26422005
Schizophr Bull. 2012 Mar;38(2):247-57
pubmed: 22258882
Am J Psychiatry. 2013 Jul;170(7):734-41
pubmed: 23599019
Nat Rev Neurosci. 2008 Mar;9(3):182-94
pubmed: 18270514
Neuroimage. 2010 Jan 15;49(2):1875-85
pubmed: 19770054
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Biol Psychiatry. 2000 Oct 15;48(8):778-90
pubmed: 11063974
J Affect Disord. 2016 Oct;203:101-110
pubmed: 27285723
PLoS One. 2016 Apr 15;11(4):e0153557
pubmed: 27082442
Psychol Med. 2013 Jun;43(6):1133-49
pubmed: 22850401
IEEE Trans Med Imaging. 2009 Jun;28(6):822-37
pubmed: 19068424
Neurobiol Dis. 2013 Apr;52:24-37
pubmed: 22426398
Br J Psychol. 2001 Nov;92(Pt 4):673-96
pubmed: 11762868
Am J Psychiatry. 2013 Jul;170(7):742-50
pubmed: 23639948
J Affect Disord. 2019 Jan 15;243:564-574
pubmed: 29625792
Transl Psychiatry. 2016 Jul 26;6(7):e859
pubmed: 27459724
Schizophr Res. 2015 Feb;161(2-3):169-76
pubmed: 25497442
Psychiatry Res. 2015 Aug 30;228(3):633-40
pubmed: 26099657
JAMA Psychiatry. 2013 Sep;70(9):940-8
pubmed: 23863946
Arch Gen Psychiatry. 2000 Nov;57(11):1053-8
pubmed: 11074871
Am J Psychiatry. 2016 Oct 1;173(10):997-1006
pubmed: 26988628
Neuroimage. 2015 Jul 15;115:117-37
pubmed: 25936807
Neuroimage. 2012 Jul 16;61(4):1402-18
pubmed: 22430496
Schizophr Bull. 2012 Nov;38(6):1162-9
pubmed: 21799213
Psychol Med. 2012 Sep;42(9):1857-63
pubmed: 22225730
Front Psychiatry. 2019 May 13;10:298
pubmed: 31133894
Mol Psychiatry. 2016 Apr;21(4):585
pubmed: 26283641
Arch Gen Psychiatry. 2012 May;69(5):467-75
pubmed: 22213772
Psychol Med. 2010 Dec;40(12):1935-42
pubmed: 20624330
Schizophr Res. 2010 Oct;123(1):71-6
pubmed: 20580205
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
Schizophr Bull. 2013 Sep;39(5):1018-26
pubmed: 22927672
Am J Psychiatry. 2016 Apr 1;173(4):392-9
pubmed: 26684922
Front Neuroanat. 2019 Feb 18;13:14
pubmed: 30833890
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11050-5
pubmed: 10984517
Am J Psychiatry. 2000 Jan;157(1):16-25
pubmed: 10618008
Schizophr Bull. 2008 May;34(3):568-79
pubmed: 18003630
Am J Psychiatry. 2011 Jan;168(1):65-72
pubmed: 20952460
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Schizophr Bull. 2012 Mar;38(2):239-46
pubmed: 22101962
Front Behav Neurosci. 2019 May 08;13:98
pubmed: 31139061
JAMA. 2001 Apr 25;285(16):2094-100
pubmed: 11311098
Biol Psychiatry. 2019 Mar 15;85(6):487-497
pubmed: 30528746
Cereb Cortex. 2004 Jan;14(1):11-22
pubmed: 14654453
Neuroimage. 2010 Aug 1;52(1):62-8
pubmed: 20399273
Psychol Med. 2013 Jul;43(7):1353-63
pubmed: 23186886
Arch Gen Psychiatry. 2011 Feb;68(2):128-37
pubmed: 21300943
JAMA Psychiatry. 2015 Jul;72(7):668-77
pubmed: 25923212
Front Psychiatry. 2012 Nov 12;3:96
pubmed: 23162479
Hum Brain Mapp. 2015 Jul;36(7):2629-43
pubmed: 25832856
JAMA Psychiatry. 2017 Nov 1;74(11):1104-1111
pubmed: 28973084
Brain Imaging Behav. 2012 Mar;6(1):49-60
pubmed: 22045236
Chronic Stress (Thousand Oaks). 2019 May 23;3:2470547019849376
pubmed: 32440594
JAMA Psychiatry. 2015 May;72(5):456-65
pubmed: 25785510
Neuroimage. 2004 Oct;23(2):724-38
pubmed: 15488422
JAMA Psychiatry. 2016 May 1;73(5):515-24
pubmed: 26982085
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Curr Top Behav Neurosci. 2010;4:529-53
pubmed: 21312412
Mol Psychiatry. 2015 Dec;20(12):1508-15
pubmed: 26033240
Psychol Med. 2009 Apr;39(4):625-34
pubmed: 18606046
Schizophr Res. 2010 Jun;119(1-3):258-65
pubmed: 20347272
Biol Psychiatry. 2019 Mar 15;85(6):436-438
pubmed: 30777168
Neuroimage. 1999 Feb;9(2):195-207
pubmed: 9931269
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573
J Psychiatr Res. 2017 Mar;86:58-65
pubmed: 27918926
Epidemiol Psichiatr Soc. 2006 Oct-Dec;15(4):252-7
pubmed: 17203616
Transl Psychiatry. 2016 Aug 09;6(8):e868
pubmed: 27505231

Auteurs

Ana Calvo (A)

Dept. of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland.
Faculty of Health Sciences, Universidad Internacional de la Rioja (UNIR), Madrid, Spain.
Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid, Spain.

Darren W Roddy (DW)

Dept. of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland.
Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.

Helen Coughlan (H)

Dept. of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland.

Ian Kelleher (I)

Dept. of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland.

Colm Healy (C)

Dept. of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland.

Michelle Harley (M)

Dept. of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland.

Mary Clarke (M)

Dept. of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland.

Alexander Leemans (A)

Image Sciences Institute University Medical Center Utrecht, Utrecht, the Netherlands.

Thomas Frodl (T)

Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
Department and Hospital of Psychiatry and Psychotherapy, Otto von Guericke University Mageburg, Mageburg, Germany.
German Center for Neurodegenerative Diseases (DZNE), Site Magdeburg, Magdeburg, Germany.

Erik O'Hanlon (E)

Dept. of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland.
Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.

Mary Cannon (M)

Dept. of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland.
Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH